KalVista Pharmaceuticals Inc (KALV)
12.13
-0.04
(-0.33%)
USD |
NASDAQ |
May 03, 16:00
12.14
+0.01
(+0.08%)
After-Hours: 20:00
KalVista Pharmaceuticals Price to Book Value: 5.777 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 5.777 |
| May 02, 2024 | 5.796 |
| May 01, 2024 | 5.801 |
| April 30, 2024 | 5.406 |
| April 29, 2024 | 5.244 |
| April 26, 2024 | 5.134 |
| April 25, 2024 | 4.996 |
| April 24, 2024 | 4.929 |
| April 23, 2024 | 5.339 |
| April 22, 2024 | 5.448 |
| April 19, 2024 | 5.510 |
| April 18, 2024 | 5.477 |
| April 17, 2024 | 5.548 |
| April 16, 2024 | 5.658 |
| April 15, 2024 | 5.591 |
| April 12, 2024 | 5.663 |
| April 11, 2024 | 5.763 |
| April 10, 2024 | 5.682 |
| April 09, 2024 | 5.625 |
| April 08, 2024 | 5.258 |
| April 05, 2024 | 5.282 |
| April 04, 2024 | 5.339 |
| April 03, 2024 | 5.363 |
| April 02, 2024 | 5.258 |
| April 01, 2024 | 5.429 |
| Date | Value |
|---|---|
| March 28, 2024 | 5.648 |
| March 27, 2024 | 5.272 |
| March 26, 2024 | 5.291 |
| March 25, 2024 | 5.301 |
| March 22, 2024 | 5.644 |
| March 21, 2024 | 5.786 |
| March 20, 2024 | 5.825 |
| March 19, 2024 | 5.639 |
| March 18, 2024 | 5.710 |
| March 15, 2024 | 5.682 |
| March 14, 2024 | 5.920 |
| March 13, 2024 | 5.948 |
| March 12, 2024 | 5.948 |
| March 11, 2024 | 6.239 |
| March 08, 2024 | 6.839 |
| March 07, 2024 | 6.573 |
| March 06, 2024 | 6.749 |
| March 05, 2024 | 6.561 |
| March 04, 2024 | 6.585 |
| March 01, 2024 | 6.636 |
| February 29, 2024 | 6.406 |
| February 28, 2024 | 6.284 |
| February 27, 2024 | 6.862 |
| February 26, 2024 | 6.425 |
| February 23, 2024 | 5.904 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6279
Minimum
Oct 19 2022
17.40
Maximum
Feb 16 2021
2.997
Average
2.325
Median
Nov 21 2023
Price to Book Value Benchmarks
| Haemonetics Corp | 5.082 |
| Perspective Therapeutics Inc | 14.13 |
| Electromed Inc | 3.946 |
| Xtant Medical Holdings Inc | 2.156 |
| Asensus Surgical Inc | 1.962 |
Price to Book Value Related Metrics
| PS Ratio | 32.94 |
| PEG Ratio | -0.4534 |
| Price | 12.13 |
| Earnings Yield | -25.97% |
| Market Cap | 511.74M |
| PEGY Ratio | -0.4534 |